Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | WRN | Q14191 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16072051 | 1.00 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1CYP2C19HPGDCYP1A2 | |
| SCHEMBL16483737 | 0.89 | SMN1; SMN2 (0.33) | SMN1; SMN2ALDH1A1CYP2C19HPGDCYP1A2 | |
| SCHEMBL159817 | 0.84 | LMNA (0.46) | ALDH1A1CYP2C19HPGDCYP1A2BLM | |
| SCHEMBL890390 | 0.84 | LMNA (0.46) | ALDH1A1CYP2C19HPGDCYP1A2BLM | |
| SCHEMBL485615 | 0.83 | MGLL (0.44) | SMN1; SMN2ALDH1A1HPGDBLMPKM | |
| Hydrochloric Acid SCHEMBL25415692 | 0.83 | LMNA (0.44) | ALDH1A1CYP2C19HPGDCYP1A2BLM | |
| SCHEMBL18033768 | 0.83 | ALDH1A1 (0.36) | SMN1; SMN2ALDH1A1CYP2C19HPGDCYP1A2 | |
| SCHEMBL18963599 | 0.83 | ALDH1A1 (0.36) | ALDH1A1CYP2C19HPGDCYP1A2BLM | |
| SCHEMBL12013343 | 0.83 | ALDH1A1 (0.40) | ALDH1A1CYP2C19HPGDCYP1A2BLM | |
| SCHEMBL24515098 | 0.83 | ALDH1A1 (0.36) | SMN1; SMN2ALDH1A1CYP2C19HPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1711163-A2 | DISPERSIONS PREPARED BY USE OF SELF-STABILIZING AGENTS | BAXTER INTERNATIONAL INC. (US) | 2006-10-18 | — | — | EP | claimed |
| EP-1605914-A1 | METHOD FOR PREPARING SMALL PARTICLES | BAXTER INTERNATIONAL INC. (US) | 2005-12-21 | — | — | EP | claimed |
| US-20050196416-A1 | Dispersions prepared by use of self-stabilizing agents | BAXTER HEALTHCARE S.A. (CH) | 2005-09-08 | — | — | US | claimed |
| WO-2005077337-A2 | DISPERSIONS PREPARED BY USE OF SELF-STABILIZING AGENTS | BAXTER INTERNATIONAL INC. (US) | 2005-08-25 | — | — | WO | claimed |
| WO-2004082659-A1 | METHOD FOR PREPARING SMALL PARTICLES | BAXTER INTERNATIONAL INC. (US) | 2004-09-30 | — | — | WO | claimed |
| US-20040022862-A1 | Method for preparing small particles | BAXTER INTERNATIONAL INC. | 2004-02-05 | — | — | US | claimed |
| EP-0306168-A1 | Preparation of radiolabeled conjugates | IMMUNOMEDICS, INC. (US) | 1989-03-08 | — | — | EP | claimed |
| EP-4746921-A1 | DRUG CONJUGATES OF IMIDAZOQUINOLINE AMINE DERIVATIVES, COMPOSITIONS AND METHODS THEREOF | Canwell Biotech Limited (CN) | 2026-05-27 | — | — | EP | disclosed |
| EP-4720629-A1 | FLOW CELL DEVICES AND OPTICAL SYSTEMS FOR IN SITU NUCLEIC ACID SEQUENCING | Element Biosciences, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260078443-A1 | FLOW CELL DEVICES AND OPTICAL SYSTEMS FOR IN SITU NUCLEIC ACID SEQUENCING | ELEMENT BIOSCIENCES INC (US) | 2026-03-19 | — | — | US | disclosed |
| CN-119546346-A | Conjugate of camptothecins combined with DDX5 protein and acid sensitive joint and immune conjugate using the same | 匹诺生物股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-115103691-B | Pharmaceutical composition containing antibody drug conjugate and application thereof | 苏州盛迪亚生物医药有限公司 | 2025-01-24 | — | — | CN | disclosed |
| WO-2025015586-A1 | DRUG CONJUGATES OF IMIDAZOQUINOLINE AMINE DERIVATIVES, COMPOSITIONS AND METHODS THEREOF | CANWELL BIOTECH LIMITED (CN) | 2025-01-23 | — | — | WO | disclosed |
| US-20040256749-A1 | Process for production of essentially solvent-free small particles | BAXTER INTERNATIONAL INC. | 2004-12-23 | — | — | US | disclosed |
| US-20040245662-A1 | Method for preparing submicron particles of antineoplastic agents | BAXTER HEALTHCARE S.A. (CH) | 2004-12-09 | — | — | US | disclosed |
| WO-2004103348-A2 | SOLID PARTICLES COMPRISING AN ANTICONVULSANT OR AN IMMUNOSUPPRESSIVE COATED WITH ONE OR MORE SURFACE MODIFIERS | BAXTER INTERNATIONAL INC. (US) | 2004-12-02 | — | — | WO | disclosed |
| WO-2004096180-A1 | FORMULATION TO RENDER AN ANTIMICROBIAL DRUG POTENT AGAINST ORGANISMS NORMALLY CONSIDERED TO BE RESISTANT TO THE DRUG | BAXTER INTERNATIONAL INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004084860-A2 | METHODS FOR THE COMMINUTION AND STABILIZATION OF SMALL PARTICLES IN SUSPENSION | BAXTER INTERNATIONAL INC. (US) | 2004-10-07 | — | — | WO | disclosed |
| WO-2004082659-A1 | METHOD FOR PREPARING SMALL PARTICLES | BAXTER INTERNATIONAL INC. (US) | 2004-09-30 | — | — | WO | disclosed |
| US-20040022862-A1 | Method for preparing small particles | BAXTER INTERNATIONAL INC. | 2004-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078443-A1 | FLOW CELL DEVICES AND OPTICAL SYSTEMS FOR IN SITU NUCLEIC ACID SEQUENCING | DNMT3A, MTHFD1, CPSF6 | SMN1; SMN2 2047/4885ALDH1A1 1649/4885CYP2C19 3772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.